31 results on '"Berger, Thomas"'
Search Results
2. Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-naive Patients with High-activity, Early-stage Relapsing-remitting Multiple Sclerosis in the ENSEMBLE Study (P10-6.007)
3. Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review
4. Reader response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
5. Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis
6. Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis.
7. Progressive multifocal leukoencephalopathy: Are you aware of it?
8. TELE MS: A Randomized Controlled Trial Investigating Remote Visits in People with Multiple Sclerosis (P18-4.007)
9. haMSter: a Smartphone Application for Remote Patient Monitoring (P18-4.003)
10. Dimethyl Fumarate Demonstrates Treatment Effectiveness in Patients One Year After Switching From Teriflunomide (P3-4.005)
11. HaMSter: a Smartphone Application for Tracking Patient Reported Outcomes in People with Multiple Sclerosis (4566)
12. Temporal and spatial patterns of inflammation and oxidative injury in human SCI (653)
13. Serum Neurofilament Light Chain Concentrations Withstand Delayed Freezing up to 24 Hours – a Pre-analytical Study. (2108)
14. Increased Serum Neurofilament Light Chain Concentration Indicates Poor Outcome in Guillain-Barré Syndrome (2414)
15. Retinal layer thinning rate as a biomarker predicting treatment response in relapsing multiple sclerosis (307)
16. Longitudinal stability of anti–JC virus (JCV) antibody index over 2 years in multiple sclerosis (MS) patients treated with natalizumab in the ASCEND study (P4.2-009)
17. Neurofilament light chain
18. Impact of disease-modifying treatments on the longitudinal evolution of anti-JCV antibody index in multiple sclerosis (P5.356)
19. Treatment of MOG-IgG-associated demyelination with Rituximab: a multinational study of 98 patients (S13.003)
20. Progressive multifocal leukoencephalopathy
21. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome
22. Effectiveness of Delayed-release Dimethyl Fumarate on Clinical Measures and Patient-reported Outcomes in Newly Diagnosed and Other Early Relapsing-Remitting Multiple Sclerosis Patients: Subgroup Analysis of PROTEC (P6.363)
23. Escalation therapy for multiple sclerosis in Austria: analysis of gender differences in the nationwide registry (P2.404)
24. Odor identification is associated with neurodegeneration in relapsing-remitting multiple sclerosis (P2.360)
25. Olfactory threshold predicts short term relapse activity in relapsing-remitting multiple sclerosis (P2.347)
26. Disease Course in Elderly MS Patients (P2.084)
27. Stability of Anti-JCV Antibody Index in Multiple Sclerosis: A 6-Year Longitudinal Study (P3.067)
28. Efficacy of Teriflunomide in Early-Stage MS: Reanalysis of the TOPIC Study Using 2010 McDonald Diagnostic Criteria (P7.274)
29. Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis.
30. Combining MRI Activity with Markers of Myelin Damage in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis.
31. Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.